Insurance barriers and distribution challenges are marring the rollout of highly anticipated new shots to protect babies from respiratory syncytial virus (RSV) and young kids from COVID-19, drawing anger and frustration from parents and pediatricians. Medical practices don’t know when, or how much, they will get paid for the pricey RSV shot, and they are…
The American Academy of Pediatrics (AAP) renews its recommendation that all children ages 6 months and older receive a flu vaccine this fall to prevent severe illness. Children younger than 5 years, especially those younger than 2 years, and children with certain underlying medical conditions are particularly vulnerable.